Form 4 for CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE
Accepted 2024-04-05 00:00:00 ET · period of report 2024-04-03 · accession 0001801170-24-000086 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-04-05 | 2024-04-03 | CLOV | Reynoso Jamie L. | CEO, Medicare Advantage | F - Tax | $0.76 | -5,387 | 2.47M | -0.2% | -$4,094 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-04-03 | F | D | 5,387 | $0.76 | 2,467,229 | D | — | — | (F1) Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on April 3, 2024, of 6.25% of the restricted stock units ("RSUs") granted to the Reporting Person on January 3, 2023, and originally reported on a Form 4 filed on January 5, 2023. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on January 3, 2027, in each case subject to the continued service of the Reporting Person on each such vesting date. |